Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protective Effect of Aspirin on COVID-19 Patients

NCT04365309 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT04365309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04365309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protective Effect of Aspirin on COVID-19 Patients
Lead sponsor
Xijing Hospital
Phase
Phase 2/3
Overall status
Unknown status
Start date
February 10, 2020
Completion date
June 30, 2020
Enrollment
128 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aspirin, novel coronavirus pneumonia, treatment